OVERVIEW
We research and develop biopharmaceutical products based on our patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. We believe the following areas of research offer the greatest potential for our product development efforts:
- Vaccines for use in high-risk populations for infectious disease targets for which there are significant U.S. needs,
- Vaccines for general pediatric, adolescent and adult populations for infectious disease applications, and
- Cancer vaccines or immunotherapies which complement our existing programs and core expertise.
ANNUAL REPORTS
For a more detailed review of Vical's programs, status and outlook, we encourage you to review our SEC Filings in the Investors section of our website as well as our latest Annual Report (below).
